Abstract:So far, about 130 disinfection by-products (DBPs) and several DBPs-groups have had their potential endocrine-disrupting effects tested on some endocrine endpoints. However, it is still not clear which specific DBPs, DBPs-groups/subgroups may be the most toxic substances or groups/subgroups for any given endocrine endpoint. In this study, we attempt to address this issue. First, a list of relevant DBPs was updated, and 1187 DBPs belonging to 4 main-groups (aliphatic, aromatic, alicyclic, heterocyclic) and 84 subgroups were described. Then, the high-priority endocrine endpoints, DBPs-groups/subgroups, and specific DBPs were determined from 18 endpoints, 4 main-groups, 84 subgroups, and 1187 specific DBPs by a virtual-screening method. The results demonstrate that most of DBPs could not disturb the endocrine endpoints in question because the proportion of active compounds associated with the endocrine endpoints ranged from 0 (human thyroid receptor beta) to 32% (human transthyretin (hTTR)). All the endpoints with a proportion of active compounds greater than 10% belonged to the thyroid system, highlighting that the potential disrupting effects of DBPs on the thyroid system should be given more attention. The aromatic and alicyclic DBPs may have higher priority than that of aliphatic and heterocyclic DBPs by considering the activity rate and potential for disrupting effects. There were 2 (halophenols and estrogen DBPs), 12, and 24 subgroups that belonged to high, moderate, and low priority classes, respectively. For individual DBPs, there were 23 (2%), 193 (16%), and 971 (82%) DBPs belonging to the high, moderate, and low priority groups, respectively. Lastly, the hTTR binding affinity of 4 DBPs was determined by an in vitro assay and all the tested DBPs exhibited dose-dependent binding potency with hTTR, which was consistent with the predicted result. Thus, more efforts should be performed to reveal the potential endocrine disruption of those high research-priority main-groups, subgroups, and individual DBPs.

Estrogen Receptor Affinity Chromatography: a New Method for Characterization of Novel Estrogenic Disinfection By-Products.

Molecular Modeling and Molecular Dynamics Simulation Studies on the Interactions of Hydroxylated Polychlorinated Biphenyls with Estrogen Receptor-β

The Removal of Estrogenic Activity with UV/chlorine Technology and Identification of Novel Estrogenic Disinfection By-Products

Investigation of Diethylstilbestrol Residue Level in Human Urine Samples by a Specific Monoclonal Antibody

An ultra-sensitive monoclonal antibody-based enzyme-linked immunosobent assay for dibutyl phthalate in human urinary

The Estrogen Receptor Relative Binding Affinities of 188 Natural and Xenochemicals: Structural Diversity of Ligands.

Hollow Fiber Liquid-Liquid-liquid Microextraction Combined with High Performance Liquid Chromatography-Ultraviolet Detection for the Determination of Various Environmental Estrogens in Environmental and Biological Samples.

Comparative in vitro and in silico study on the estrogenic effects of 2,2-bis(4-chlorophenyl)ethanol, 4,4′-dichlorobenzophenone and DDT analogs

Molecular Docking and Molecular Dynamics Studies on the Interactions of Hydroxylated Polybrominated Diphenyl Ethers to Estrogen Receptor Alpha.

Occurrence and removal efficiencies of eight EDCs and estrogenicity in a STP.

Development of Monoclonal Antibody-based Enzyme-linked Immunosorbent Assay to the Estrogen Diethylstilbestrol

Exploring the binding features of polybrominated diphenyl ethers as estrogen receptor antagonists: docking studies

In Silico Study of Molecular Mechanisms of Action: Estrogenic Disruptors among Phthalate Esters.

Estrogenicity of halogenated bisphenol A: in vitro and in silico investigations

Discriminating the endogenous and exogenous urinary estrogens in human by isotopic ratio mass spectrometry and its potential clinical value.

Recognizing high-priority disinfection byproducts based on experimental and predicted endocrine disrupting data: Virtual screening and in vitro study

Comparison Study on Three Methods to Assay DES Residue with HPLC, FS and CZE

In Vitro Profiling of the Endocrine Disrupting Potency of Organochlorine Pesticides

Multiplex Analysis Platform for Evaluation of Endocrine Disruption of Emerging Contaminants Against Human Steroid Hormone Receptors Using Autobioluminescent Yeast Bioassay: Application to Bisphenols

An Integrated "4-Phase" Approach for Setting Endocrine Disruption Screening Priorities--phase I and II Predictions of Estrogen Receptor Binding Affinity

Estrogen Receptor‐based Multi‐residue Screening of Bisphenol Compounds in Urine